Warning: Undefined array key "url" in /www/wwwroot/mnbt.11370829f/wp-content/plugins/wpforms-lite/src/Forms/IconChoices.php on line 127

Warning: Undefined array key "path" in /www/wwwroot/mnbt.11370829f/wp-content/plugins/wpforms-lite/src/Forms/IconChoices.php on line 128
RIP (free acid) - Best Biochem | Custom Peptide | Protein | Antibody | RNA oligos | Inhibitor Skip to content
Best Biochem | Custom Peptide | Protein | Antibody | RNA oligos | Inhibitor Logo
  • About us
    • Home
  • About us
    • Home

RIP (free acid)

Home/Antimicrobial Peptides/RIP (free acid)
RIP (free acid)Admin2020-08-25T03:19:25+00:00
Product Name RIP (free acid)
Purity HPLC>95%
Description The heptapeptide YSPWTNF has been shown to prevent cellulitis in mice, which was induced by S. aureus strain Smith diffuse. Furthermore, RIP can also significantly reduce the overall pathology and delay the onset of disease symptoms in several other S. aureus infections, including keratitis, osteomyelitis, mastitis, and septic arthritis. These findings strongly evidence the potential value of RIP as a chemotherapeutic agent.
Storage -20°C
References N.Balaban et al., Peptides, 21, 1301 (2000)
Molecular Weight 913.99
Sequence (One-Letter Code) YSPWTNF
Sequence (Three-Letter Code) H-Tyr-Ser-Pro-Trp-Thr-Asn-Phe-OH

Other Products

  • Research peptides
  • Antibodies
  • Drug for research
  • Inhibitor and agonist

Related Products

  • LL-37 amide
  • T20
  • 5-FAM-LL-37
  • Cecropin A
  • Hispidalin
  • Elafin
Contact us
  • Skype: elisa.qiujx
  • elisa@bestbiochem.com
  • WeChat

  • QQ: 1652852700

CUSTOM SERVICES

  • Peptide Synthesis
  • Antibody Production
  • DNA/RNA Synthesis

CHARACTERISTIC PRODUCTS

  • Research Peptide
  • Antibody
  • API and Impurity
  • Inhibitor and Agonist

Contact Info

No. 199 Huayuan Dong Road, Wuzhong Qu,Suzhou Shi, Jiangsu Sheng, China

Phone: +86 18021243762 (same as Wechat)

Email: info@bestbiochem.com

Web: bestbiochem.com

Recent Tweets

Copyright 2012 - 2017 BestBiochem | All Rights Reserved
LinkedInFacebookTwitter
Go to Top